First MND Insight Research findings: Many Kiwis missing out on life-extending treatment
Motor Neurone Disease NZ (MND NZ) is delighted to announce the publication of the first academic paper…
Motor Neurone Disease NZ (MND NZ) is delighted to announce the publication of the first academic paper…
Dr Natalie Gauld ONZM, Research Advisor and Best Practice Advocate at MND NZ, will be presenting to…
Research is essential for improving the lives of people with motor neurone disease (MND) and their whānau….
Due to the overwhelming response to our September 2025 webinar, Dr Natalie Gauld and Mark Leggett will…
Motor Neurone Disease NZ welcomes the appointment of Professor Hanneke Hulst as the next Director of the…
A research initiative led by Associate Professor Emma Scotter (Centre for Brain Research, The University of Auckland),…
The 2025 MND Insight Research study — formerly known as the MND Insight Survey — has reached…
A treatment for motor neurone disease (MND) has been newly added to Australia’s Pharmaceutical Benefits Scheme (PBS),…
We want to share an important update with our community: the Lighthouse II clinical trial has been…
The MND Insight Survey 2025 is the most comprehensive survey of the motor neurone disease (MND) community…
Improving care, support, and advocacy for people with MND Motor neurone disease (MND) is life-changing, affecting not…
Building a clearer picture of motor neurone disease (MND) to improve care and drive change Research is…